반응형
Global Data Intelligence Center
구분 보고서 (영문) 업로드 날짜
제약/바이오/임상시험 Merck’s MK-0616 Holds Potential to Become the First Oral PCSK9 Inhibitor in the Dyslipidemia Market 03-09-2023
More Positive Data for Daiichi Sankyo and AstraZeneca’s Blockbuster Drug Enhertu 03-09-2023
The State of the Oncology Microbiome Therapeutics Pipeline at a Glance 03-08-2023
Eli Lilly Places Price Cap of $35 on Out-of-Pocket Insulin Cost 03-07-2023
Positive Results for PD-1 Inhibitors in Front-Line Gastric Cancer, But Who Can Compete With Opdivo? 03-03-2023
Toripalimab Can Become the New Standard of Care in Recurrent/Metastatic Nasopharyngeal Carcinoma 03-03-2023
Contract Manufacturing: Opportunities and Threats February 2023 03-02-2023
February Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing Q1 2023 03-02-2023
Nubeqa Approval to Boost Bayer’s Presence in Prostate Cancer Market in Japan 03-01-2023
질환별 30 Years of Failed Trials Put Sepsis on Track to Be the Main Cause of Death by 2050 03-09-2023
Angelman Syndrome: Competitive Landscape 03-06-2023

반응형

+ Recent posts